Tobacco use remains a significant global health challenge, despite extensive control measures at both national and international levels.
Selective androgen receptor modulator has anti-tumor effects in ER-positive breast cancer patients
A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the